4,4,5,5-Tetramethyl-2-(2-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane, 95.0%, 5g

(4R)-(-)-5,5-Dimethyl-2-hydroxy-4-phenyl-1,3,2-dioxaphosphinane 2-oxide hydrate, 97%, 250mg

trans-4-Phenylcyclohexaneacetic acid, 95%, 250mg

Tetraammineplatinum (II) chloride hydrate, 95.0%, 1g

Prohibition signs tested in practice, Access prohibited for unauthorized persons, 1 piece

6-Fluoro-2H-1,4-benzoxazin-3(4H)-one, 95.0%, 25g

2',7'-Difluorofluorescein, 98+%, 100mg

4-Amino-N-isopropylbenzenesulfonamide, 95.0%, 250mg

(R)-2-(tert-butyl)-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole, 97%, 250mg

1-(4-Amino-2-chloropyridin-3-yl)ethanone, 97%, 100mg

6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-2-carbaldehyde, 97%, 1g

1,3-Phenylenediamine-4-sulfonic Acid>98.0%(HPLC)(T)500g

tert-Butyl 2-(5-ethyl-2,4-dioxooxazolidin-3-yl)ethylcarbamate, 50mg